Safety and efficacy analyses of atezolizumab in advanced non-small cell lung cancer (NSCLC) patients with or without baseline brain metastases

ANNALS OF ONCOLOGY

OXFORD UNIV PRESS

1. F. Hoffmann-La Roche Ltd/Genentech Inc. of the Roche Group